Juvenescence

Visit website

overall

1,261

out of 62,432

-63

traffic

13,953

out of 62,432

+47

investment

396

out of 62,432

-45

review

Not Available

These rankings are based on data from March 2026

Company

Juvenescence

Years in business

Number of employees

11-50 employees

Country

United Kingdom

Juvenescence develops innovative medicines targeting aging mechanisms to treat and prevent age-related diseases, enhancing healthy lifespan through AI-enabled R&D and adaptive clinical trials.

API Availability

Unknown

Pricing

unknown

Use

clinical trial management

drug discovery & development

Position of Juvenescence on sub rankings

March 2026

AI drug discovery & development - Overall

2 out of 62

United Kingdom - Overall

68 out of 3,129

AI drug discovery & development - Overall

2 out of 62

United Kingdom - Overall

68 out of 3,129

Industries

health & sports

Company

Juvenescence

Years in business

Number of employees

11-50 employees

Country

United Kingdom

Help us improve this profile

Insights

Sune Selsbæk-Reitz on promptism, fluent machines, and why AI makes it easier to stop thinking too soon

An interview with Sune Selsbæk-Reitz on his new book Promptism and why the real risk of AI is not in the technology itself, but in how we use it. He explains how fluent systems influence thinking, why knowledge matters more than ever, and what professionals should do to stay in control.

9 Fresh AI Tools: From scam checks to startup plans

This month brought another strong batch of new submissions to RankmyAI. Thanks again to the builders and users who keep pointing us to tools we should track.